Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CALCRLCHRM1CHRM2CHRM3F2RMAOAMAOBMAP2K1MAP2K2NTRK1NTRK2NTRK3OPRD1OPRK1OPRM1P2RY12PKLRSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASLC18A2SLC6A2SLC6A3TLR7TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8dacAdacBdacCfolAftsImrcAmrcBmrdApolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmB1rpmB2rpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmHrpmIrpmJrpmJ2rpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsR1rpsR2rpsSrpsTrpsUrpsZykgMykgO
The experimentally established mechanism targets of Tetrabuthylammonium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 0.67 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.58 |
| ▸ | TP53 | P04637 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL27990806 | 1.00 | SLC22A1 (0.67) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28652896 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 | |
| Tetrabuthylammonium SCHEMBL9795128 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 | |
| Tetrabuthylammonium SCHEMBL27541838 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28646345 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 | |
| Tetrabuthylammonium SCHEMBL28650063 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 | |
| Tetrabuthylammonium SCHEMBL9998667 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 | |
| Tetrabuthylammonium SCHEMBL1078546 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 | |
| Tetrabuthylammonium SCHEMBL20550034 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 | |
| Tetrabuthylammonium SCHEMBL27745678 | 0.97 | SLC22A1 (0.63) | SLC22A1SLC22A2TP53ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1933 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122079810-A | Aromatic diamine and polyimide containing amido, preparation method and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| EP-4705547-A1 | PROCESS FOR THE PREPARATION OF 1,1,4,4-TETRAALKYLOXY-2-BUTENE | DSM IP Assets B.V. (NL) | 2026-03-11 | — | — | EP | claimed |
| CN-116726545-B | Magnetic solid phase extraction method and application thereof | 中国水产科学研究院南海水产研究所 | 2026-02-27 | — | — | CN | claimed |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | ENTEGRIS INC (US) | 2026-01-15 | — | — | US | claimed |
| US-20250353823-A1 | PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN | DSM IP ASSETS BV (NL) | 2025-11-20 | — | — | US | claimed |
| CN-120040411-A | Method for preparing aryl crown ether compound by one-pot method | 浙江大学衢州研究院 | 2025-05-27 | — | — | CN | claimed |
| WO-2025106486-A1 | AQUEOUS ZN-TETRAZINE BATTERIES | OHIO STATE INNOVATION FOUNDATION (US) | 2025-05-22 | — | — | WO | claimed |
| EP-4540440-A1 | PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN | DSM IP Assets B.V. (NL) | 2025-04-23 | — | — | EP | claimed |
| CN-119161652-B | Composite drainage net material and preparation method thereof | 山东亿博阳光工程材料有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119613418-A | Dodecaurea cage type molecule, preparation method and application | 北京理工大学 | 2025-03-14 | — | — | CN | claimed |
| WO-1998018871-A1 | ORGANIC SOLVENT BASED INK FOR INVISIBLE MARKING/IDENTIFICATION | EASTMAN CHEMICAL COMPANY (US) | 1998-05-07 | — | — | WO | claimed |
| EP-0827496-A1 | CATALIC ENANTIOSELECTIVE SYNTHESIS OF A SPIRO-FUSED AZETIDINONE | SCHERING CORPORATION (US) | 1998-03-11 | — | — | EP | claimed |
| US-5648484-A | Catalytic enantioselective synthesis of a spriofused azetidinone | SCHERING CORPORATION (US) | 1997-07-15 | — | — | US | claimed |
| WO-1996027587-A1 | CATALIC ENANTIOSELECTIVE SYNTHESIS OF A SPIRO-FUSED AZETIDINONE | SCHERING CORPORATION (US) | 1996-09-12 | — | — | WO | claimed |
| US-5159089-A | Using a sulfur methylide compound | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1992-10-27 | — | — | US | claimed |
| EP-0263205-A1 | Processes for the preparation of compounds comprising substituted phenyl rings | THE UPJOHN COMPANY (US) | 1988-04-13 | — | — | EP | claimed |
| US-4730049-A | Process for preparing 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno (3,2-C)pyridine | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1988-03-08 | — | — | US | claimed |
| EP-0231257-A1 | CHEMICAL COMPOUNDS COMRPISING SUBSTITUTED PHENYLRINGS | THE UPJOHN COMPANY (US) | 1987-08-12 | — | — | EP | claimed |
| WO-1987000519-A1 | CHEMICAL COMPOUNDS COMRPISING SUBSTITUTED PHENYLRINGS | THE UPJOHN COMPANY (US) | 1987-01-29 | — | — | WO | claimed |
| US-4522729-A | CXONTACTING IMPORITIES WITH TETRAALKYLAMMONIUM SALT | PHILLIPS PETROLEUM COMPANY (US) | 1985-06-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250353823-A1 | PROCESS FOR THE PREPARATION OF ALKOXYLATED 2,5-DIHYDROFURAN | CYP4F2, CYP4F12, CYP2F1 | SLC22A1 2695/4885SLC22A2 1857/4885TP53 3216/4885 |
| US-20260015560-A1 | COMPOSITIONS FOR POST-CMP CLEANING OF MICROELECTRONIC DEVICES | TET2, ASIC1, PIEZO1 | SLC22A1 2747/4885SLC22A2 2992/4885TP53 3589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.